Legault Pierre
- SEC CIK
- 0001391045
No open-market purchases or sales filed in the past year.
Current role at each company
- SNDX Syndax Pharmaceuticals IncDirectoras of Feb 6, 2026
- BCYC Bicycle Therapeutics PLCDirectoras of Jan 6, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Legault Pierre as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SNDX Syndax Pharmaceuticals Inc
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2023 (view filing) | Jan 12-13 | 1 day | Legault PierreDirector | SSale | −39.0K | $26.84 | −$1.05M | −54.9%32.0K after | 3 lots |
| Aug 9, 2022 (view filing) | Aug 5 | 4 days | Legault PierreDirector | SSale | −24.0K | $23.02 | −$552.5K | −42.9%32.0K after | 2 lots |
| Dec 22, 2021 (view filing) | Dec 20-22 | 2 days | Legault PierreDirector | SSale | −44.0K | $21.56 | −$948.4K | −73.3%16.0K after | 2 lots |
BCYC Bicycle Therapeutics PLC
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 22, 2021 (view filing) | Dec 20-22 | 2 days | Legault PierreDirector | SSale | −150.0K | $57.69 | −$8.65M | −100.0%0 after | 3 lots |